Therriault, Joseph http://orcid.org/0000-0002-7826-4781
,
Wang, S.
Mathotaarachchi, S.
Pascoal, Tharick A.
Parent, M.
Beaudry, T.
Shin, M.
AL, Benedet
Kang, M. S.
Ng, K. P.
Dansereau, C.
Park, M. T. M.
Fonov, V.
Carbonell, F.
Zimmer, E.
Chakravarty, M. Mallar
Bellec, P.
Gauthier, S.
Rosa-Neto, P.
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-11-51-31)
McGill University
Alzheimer Society (NIRG-08-92090)
Article History
Received: 19 December 2018
Accepted: 3 June 2019
First Online: 22 June 2019
Compliance with Ethical Standards
: In this section, we outline our manuscript’s compliance with all relevant ethical standards.
: Therriault J, Wang S, Mathotaarachchi S, Pascoal TA, Parent M, Beaudry T, Shin M, Benedet AL, Kang MS, Ng KP, Dansereau C, Park MTM, Fonov V, Carbonell F, Zimmer E, Chakravarty M, Bellec P, and Rosa-Neto P have no conflicts of interest to disclose. S. Gauthier has received honoraria for serving on the scientific advisory boards of Alzheon, Axovant, Lilly, Lundbeck, Novartis, Schwabe, and TauRx and on the Data Safety Monitoring Board of a study sponsored by Eisai and studies run by the Alzheimer’s Disease Cooperative Study and by the Alzheimer’s Therapeutic Research Institute.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The ADNI study was approved by the Institutional Review Boards of all of the participating institutions. Informed written consent was obtained from all participants in the study.